ESR1 and breast carcinoma: Prompted by the lack of information about CAND1’s potential as an ERα-positive breast cancer biomarker, comprehensive bioinformatics analysis was carried out utilizing several databases to evaluate the significance of CAND1 as a diagnostic tool.